Cardiol Therapeutics CRDL Q4 2025 Earnings Narrower Loss Surpasses Estimates as PreRevenue Biotech Advances Pipeline VIV Q1 2026 Earnings EPS Misses Estimates Stock Sheds 172 Caleres CAL Q1 2026 Earnings EPS Beat Helps Narrow Loss Stock Gains 38 MAZE Q1 2026 Earnings EPS Surprises to the Upside Revenue Yet to Materialize EXC Q1 2026 Earnings Slight EPS Beat Bolsters Utilitys Steady Outlook Array Digital Infrastructure Notes UZE Edge Higher Amid Steady Demand Piper Sandler PIPR Edges Lower Amid Consolidation Near Key Support Tesla TSLA Edges Higher as Stock Holds Above Key Support Level Relmada Therapeutics RLMD Narrows Near Key Support as Trading Volume Remains Subdued Voyager Acquisition Corp VACH Drops 654 Support Levels Under Pressure Scholastic Corporation SCHL Edges Higher Consolidating Between Key Levels 1RT Acquisition Corp Units ONCHU Holds Steady at 1032 Amid Quiet Trading VF Corporation VFC Holds Steady Near Support Amidst Mixed Market Signals CNX Resources CNX Slips 164 as Stock Holds Above Key Support Level Filana Therapeutics FLNA Posts Modest Gains Amid Broader Biotech Resilience Cytokinetics Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Focus Intensifies